Glycaemic control can decrease microvascular complications in patients with type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM). However, the effect of glycaemic control on macrovascular complications using currently available therapeutic options has been disappointing.

Please sign in to read more